Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2024-2034

The global OTC Drugs & Dietary Supplements market was valued at US$ 211.8 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

Visiongain Publishes Biologics Market Report 2024-2034

The biologics market is estimated at US$447 billion in 2023 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.

Visiongain Publishes mRNA Vaccines Market Report 2023-2033

The global mRNA Vaccines market is estimated at US$11,773.3 million in 2023 and is projected to grow at a CAGR of 10.5% during the forecast period 2023-2033.

Visiongain Publishes Stem Cell Technologies and Applications Market Report 2023-2033

The global Stem Cell Technologies and Applications market is estimated at US$10,059.6 million in 2023 and is projected to grow at a CAGR of 8.7% during the forecast period 2023-2033.

Visiongain Publishes Neurology Clinical Trials Market Report 2023-2033

The global Neurology Clinical Trials market is valued at US$9,609.2 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033.

Visiongain Publishes Pharma Contract Sales Market Report 2023-2033

The global Pharma Contract Sales market is valued at US$7,678.6 million in 2023 and is projected to grow at a CAGR of 8.2% during the forecast period 2023-2033.

Visiongain Publishes Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2024-2034

The global Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs market is valued at US$24.2 billion in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period 2024-2034.

Visiongain Publishes Influenza Vaccines Market Report 2023-2033

The global Influenza Vaccines market is valued at US$6,648.0 million in 2023 and is projected to grow at a CAGR of 10.5% during the forecast period 2023-2033.

Visiongain Publishes Antisense Oligonucleotide (ASO) Therapeutics Market Report 2023-2033

The global Antisense Oligonucleotide (ASO) Therapeutics market is valued at US$6,099.3 million in 2023 and is projected to grow at a CAGR of 14.5% during the forecast period 2023-2033.

Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2023-2033

The global Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is valued at US$15.6 billion in 2023 and is projected to grow at a CAGR of 7.4% during the forecast period 2023-2033.

Visiongain Publishes Orphan Drugs Market Report 2023-2033

The global Orphan Drugs market is valued at US$187.6 billion in 2022 and is projected to grow at a CAGR of 11.1% during the forecast period 2023-2033.

Visiongain Publishes 3D Cell Culture and 3D Bioprinting Market Report 2023-2033

The global 3D Cell Culture and 3D Bioprinting market is valued at US$2,277.2 million in 2023 and is projected to grow at a CAGR of 17.8% during the forecast period 2023-2033.

Visiongain Publishes Bioreactors Market Report 2023-2033

The global Bioreactors market was estimated to be valued at US$9,977.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.

Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033

The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033

The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.

Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033

The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.

Visiongain Publishes Immuno-Oncology Clinical Trials Market Report 2023-2033

Immuno-Oncology Clinical Trials market is valued at US$6,849.8 million in 2023 and is projected to grow at a CAGR of 11.3% during the forecast period 2023-2033.

Visiongain Publishes In Silico Clinical Trials Market Report 2023-2033

The global In Silico Clinical Trials market is valued at US$3,078.0 million in 2023 and is projected to grow at a CAGR of 8% during the forecast period 2023-2033.

Clients & Partners

BP logo Kelloggs logo BAE systems logo Unilever logo BASF logo 3M logo THALES logo TEVA logo Shell logo Raytheon logo Pfizer logo Lockhead Martin logo Mercedes logo Honeywell logo DUPONT logo Daimler logo Deloitte logo